By Helgi Library - April 2, 2020
Wolford's total assets reached EUR 147 mil at the end of 2014, up 6.75% compared to the previous year. Current ass...
By Helgi Library - April 2, 2020
Wolford's total assets reached EUR 147 mil at the end of 2014, up 6.75% compared to the previous year. Current ass...
Profit Statement |
Balance Sheet |
Ratios |
Valuation |
Get all company financials in excel:
Get all company financials in excel:
Wolford AG is an Austria-based manufacturer of hosiery and lingerie. The Company was founded in 1949 by Walter Palmers and Reinhold Wolf. Company's product portfolio includes: Leg wear, ranging from pantyhose, stockings, stay-ups and knee-highs to leggings and socks; Ready-to-wear products, including bodies, shirts and tops, sweaters, dresses, coats and skirts; Swimwear product group comprises beachwear, swimbodies, swimkinis, and beach accessories, such as pareos, tops, caftans and dresses; Lingerie includes bras, strings, tangas, panties and bodies, and Accessories, including scarves, foulards, handbags, purses and belt, among others. The Company operates through subsidiaries located in Europe, America, Australia, Asia and the Middle East.
Wolford has been growing its sales by a year on average in the last 5 years. EBITDA has fallen on average by 2.71% a year during that time to total of EUR 10.9 mil in 2014, or 6.45% of sales. That’s compared to 6.83% average margin seen in last five years.
The company netted EUR 1.03 mil in 2014 implying ROE of 1.38% and ROCE of 0.836%. Again, the average figures were 0.395% and 0.244%, respectively when looking at the previous 5 years.
Wolford’s net debt amounted to EUR 18.7 mil at the end of 2014, or 0.250 of equity. When compared to EBITDA, net debt was 1.71x, down when compared to average of 2.26x seen in the last 5 years.
Wolford stock traded at EUR 24.0 per share at the end of 2014 resulting in a market capitalization of USD 142 mil. Over the previous five years, stock price grew by 44.9% or 7.70% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 11.7x and price to earnings (PE) of 114x as of 2014.